Assessment of In vitro pharmacological activity of Olmesartan by analytical techniques

Authors

  • T. Rajathilagam Department of Pharmacology, ESIC Medical College, Chennai, Tamil Nadu, India
  • S. Seethalakshmi Department of Pharmacology, ESIC Medical College, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20151345

Keywords:

1, 1 Diphenyl 2-picryl hydrazide, Free radicals, In vitro, Oxidative stress, Olmesartan, Nitric oxide

Abstract

Background: Free radical oxidative stress has been implicated in the pathology of a wide variety of clinical disorders. Antioxidants are agents which scavenge the free radicals and prevent the damage caused by them. Angiotensin II receptor blockers used in the treatment of hypertension has also been reported to protect organs such as kidney and heart. Although the mechanisms of these protective effects are not fully understood, it is generally thought that their antioxidant effects likely play a role. Hence, this in vitro study was done to demonstrate the antioxidant pharmacological activity of a commonly used Angiotensin receptor blocker Olmesartan.

Methods: In this study, we demonstrated the antioxidant pharmacological activity of Olmesartan in vitro by 1,1 Diphenyl 2-picryl hydrazide (DPPH) and nitric oxide (NO) free radical scavenging assays.

Results: Olmesartan showed significant free radical scavenging activity by DPPH and NO radical scavenging assays.

Conclusion: Hence, Olmesartan, which is an antihypertensive drug, may be effective also as an antioxidant in a wide variety of disease conditions caused by oxidative stress.

References

Patel Rajesh M, Patel Natvar J. In vitro antioxidant activity of coumarin compounds by DPPH, super oxide and nitric oxide free radical scavenging methods. J Adv Pharm Educ Res. 2011;1:52-68.

Jananie RK, Priya V, Vijayalakshmi K. In vitro assessment of free radical scavenging activity of Cynodon dactylon. J Chem Pharm Res. 2011;3(4):647-54.

Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today. 2006;11(11-12):524-33.

Khanna HD, Sinha MK, Khanna S, Tandon R. Oxidative stress in hypertension: association with antihypertensive treatment. Indian J Physiol Pharmacol. 2008;52(3):

-7.

Latha S, Fatima Grace X, Shanthi S, Chamundeeswari D, Seethalakshmi S, Reddy UC. In vitro antioxidant and anti-inflammatory activity of methanol extract of Stereospermum colais. Sri Ramachandra J Med. 2011;4:11-4.

Takiguchi S, Ayaori M, Uto-Kondo H, Iizuka M, Sasaki M, Komatsu T, et al. Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase. Hypertens Res. 2011;34(6):686-92.

Kadowaki D, Anraku M, Tasaki Y, Taguchi K, Shimoishi K, Seo H, et al. Evaluation for antioxidant and renoprotective activity of olmesartan using nephrectomy rats. Biol Pharm Bull. 2009;32(12):2041-5.

Singh D, Mishra M, Gupta M, Singh P, Gupta A, Nema R. Nitric oxide radical scavenging assay of bioactive compounds present in methanol extract of Centella asiatica. Int J Pharm Pharm Sci Res. 2012;2(3):42-4.

Kedare SB, Singh RP. Genesis and development of DPPH method of antioxidant assay. J Food Sci Technol. 2011;48(4):412-22.

Marinova G, Batchvarov V. Evaluation of the methods for determination of the free radical scavenging activity by DPPH. Bulg J Agric Sci. 2011;17(1):11-24.

Downloads

Published

2017-01-16

How to Cite

Rajathilagam, T., & Seethalakshmi, S. (2017). Assessment of In vitro pharmacological activity of Olmesartan by analytical techniques. International Journal of Basic & Clinical Pharmacology, 4(6), 1129–1131. https://doi.org/10.18203/2319-2003.ijbcp20151345

Issue

Section

Original Research Articles